发明名称 TETRACYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE, AND PHARMACEUTICALS THEM CONTAINING
摘要 <p>Tetracyclic derivatives of formula (I) in which: R0 represents hydrogen, halogen or C1-6alkyl; R1 represents hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, haloC1-6alkyl, C3-8cycloalkyl, C3-8cycloalkyl C1-3alkyl, arylC1-3alkyl or heteroaryl C1-3alkyl; R2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan and pyridine or an optionally substituted bicyclic ring (a), wherein the fused ring (A) is a 5- or 6-membered ring which may be saturated or partially or fully unsaturated and comprises carbon atoms and optionally one or two heteroatoms selected from oxygen, sulphur and nitrogen; and R3 represents hydrogen or C1-3 alkyl, or R1 and R3 together represent a 3- or 4-membered alkyl or alkenyl chain. A compound of formula (I) is a potent and selective inhibitor of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase (cGMP specific PDE) having a utility in a variety of therapeutic areas where such inhibition is beneficial, including the treatment of cardiovascular disorders. Also disclosed is a method of preparing said derivatives and pharmaceutical compositions based thereon.</p>
申请公布号 SK280879(B6) 申请公布日期 2000.08.14
申请号 SK19960000940 申请日期 1995.01.19
申请人 ICOS CORPORATION 发明人 DAUGAN ALAIN CLAUDE-MARIE
分类号 C07D471/04;A01K67/033;A01N63/00;A61K31/395;A61K31/495;A61K31/4985;A61P1/00;A61P1/12;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/02;A61P13/12;A61P15/00;A61P27/02;A61P27/06;A61P27/14;A61P27/16;A61P29/00;A61P37/08;A61P43/00;C07D209/08;C07D209/14;C07D209/20;C07D471/14;(IPC1-7):C07D471/14 主分类号 C07D471/04
代理机构 代理人
主权项
地址